Designed specifically for emerging biotechs, the Early Phase Center of Excellence brings together Avance Clinical’s scientific, regulatory, and operational experts to streamline first-in-human and ...
PFE is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of PFE shares has increased $0.19 since the market last closed. This is a 0.75% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback